Ophthalmology News

Ophthal

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Gueudry J et al. - IFN-alpha 2a is efficient and safe for the long-term management of severe uveitis associated with Behçet disease. Meanwhile it seems to be a suspensive therapeutic strategy, even though long-term remission is possible in some patients.

Related Articles

FDA Approval for Uveitis Treatment for Sirion's Durezol
Review of Ophthalmology, 12/02/09    Relevance Score: 87%

Inflammatory mediators and posterior segment involvement in ocular Behcet disease
European Journal of Ophthalmology, 11/11/09    Relevance Score: 87%

Seroprevalence of Bartonella henselae in patients with uveitis and healthy individuals in Tokyo
Japanese Journal of Ophthalmology, 11/10/09    Relevance Score: 87%

Successful switching to adalimumab in an infliximab-allergic patient with severe Behcet disease-related uveitis
Rheumatology International, 11/02/09    Relevance Score: 85%

The effect of clinical severity and eyelid rash on ocular involvement in primary varicella infection
European Journal of Ophthalmology, 11/05/09    Relevance Score: 84%

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address